Estée Lauder
No proof required
Up to $5,000
Claims opening soon
N
Namenda
Manufacturers of Namenda and generic Alzheimer’s medications settled for over $56 million over price-fixing claims.
ClosedSelected statesClaim status: Closed on February 3, 2023Payout: VariesNo longer claimable
About this settlement
The case involves allegations of price-fixing for Namenda IR and XR medications and their generic equivalents.
This settlement resolves claims that manufacturers of brand-name and generic Namenda Alzheimer’s medications conspired to fix prices, resulting in over $56 million paid to affected purchasers.
Who qualifies
- Third-party payors who indirectly purchased branded Namenda IR 5 or 10 mg tablets, AB-rated generic equivalents, or Namenda XR capsules in specified states between June 1, 2012...
- Persons or entities who indirectly purchased branded Namenda IR or XR since April 14, 2010.
Varies
Claim status: Closed on February 3, 2023
Silk and Great Value
Proof required
Up to $300,000
96 days left
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
746 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon